Environmental Influences on Endothelial to Mesenchymal Transition in Developing Implanted Cardiovascular Tissue-Engineered Grafts

Publication date

2016

Authors

Muylaert, Dimitri E.P.
de Jong, Olivier G
Slaats, Gisela G GORCID 0000-0002-4567-0134
Nieuweboer, Frederieke E
Fledderus, Joost OORCID 0000-0002-7353-2572ISNI 000000039700910X
Goumans, Marie-Jose
Hierck, Beerend P
Verhaar, Marianne C.ORCID 0000-0002-3276-6428ISNI 0000000390259392

Editors

Advisors

Supervisors

Document Type

Article

Collections

License

Abstract

Tissue-engineered grafts for cardiovascular structures experience biochemical stimuli and mechanical forces that influence tissue development after implantation such as the immunological response, oxidative stress, hemodynamic shear stress, and mechanical strain. Endothelial cells are a cell source of major interest in vascular tissue engineering because of their ability to form a luminal antithrombotic monolayer. In addition, through their ability to undergo endothelial to mesenchymal transition (EndMT), endothelial cells may yield a cell type capable of increased production and remodeling of the extracellular matrix (ECM). ECM is of major importance to the mechanical function of all cardiovascular structures. Tissue engineering approaches may employ EndMT to recapitulate, in part, the embryonic development of cardiovascular structures. Improved understanding of how the environment of an implanted graft could influence EndMT in endothelial cells may lead to novel tissue engineering strategies. This review presents an overview of biochemical and mechanical stimuli capable of influencing EndMT, discusses the influence of these stimuli as found in the direct environment of cardiovascular grafts, and discusses approaches to employ EndMT in tissue-engineered constructs.

Keywords

Journal Article

Citation

Muylaert, D E P, de Jong, O G, Slaats, G G G, Nieuweboer, F E, Fledderus, J O, Goumans, M-J, Hierck, B P & Verhaar, M C 2016, 'Environmental Influences on Endothelial to Mesenchymal Transition in Developing Implanted Cardiovascular Tissue-Engineered Grafts', Tissue engineering. Part C, Methods, vol. 22, no. 1, pp. 58-67. https://doi.org/10.1089/ten.TEB.2015.0167